Using integrated modeling to support the global eradication of vaccine-preventable diseases

被引:17
|
作者
Tebbens, Radboud J. Duintjer [1 ]
Thompson, Kimberly M. [1 ]
机构
[1] Kid Risk Inc, 605 N High St,253, Columbus, OH 43215 USA
关键词
ORAL POLIOVIRUS VACCINE; COST-EFFECTIVENESS; POPULATION IMMUNITY; SENSITIVITY ANALYSES; POTENTIAL IMPACT; POLICY OPTIONS; UNITED-STATES; HEPATITIS-B; TRANSMISSION; POLIOMYELITIS;
D O I
10.1002/sdr.1589
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
The long-term management of global disease eradication initiatives involves numerous inherently dynamic processes, health and economic trade-offs, significant uncertainty and variability, rare events with big consequences, complex and interrelated decisions, and a requirement for cooperation among a large number of stakeholders. Over the course of more than 16 years of collaborative modeling efforts to support the Global Polio Eradication Initiative, we developed increasingly complex integrated system dynamics models that combined numerous analytical approaches, including differential equation-based modeling, risk and decision analysis, discrete-event and individual-based simulation, probabilistic uncertainty and sensitivity analysis, health economics and optimization. We discuss the central role of systems thinking and system dynamics in the overall effort and the value of integrating different modeling approaches to appropriately address the trade-offs involved in some of the policy questions. We discuss practical challenges of integrating different analytical tools and we provide our perspective on the future of integrated modeling. Copyright (c) 2018 System Dynamics Society
引用
收藏
页码:78 / 120
页数:43
相关论文
共 50 条
  • [21] Vaccine-Preventable Diseases in Older Adults
    Al-Jabri, Maha
    Rosero, Christian
    Saade, Elie A.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2023, 37 (01) : 103 - 121
  • [22] CURRENT STATUS OF VACCINE-PREVENTABLE DISEASES
    WITTE, JJ
    POSTGRADUATE MEDICINE, 1974, 56 (04) : 55 - 59
  • [23] GLOBAL CONTROL OF VACCINE-PREVENTABLE DISEASES - HOW PROGRESS CAN BE EVALUATED
    HENDERSON, RH
    KEJA, J
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S649 - S654
  • [24] Vaccine Refusal and the Risks of Vaccine-Preventable Diseases REPLY
    Omer, Saad B.
    Sanders, Daniel A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (07): : 723 - 724
  • [25] Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States
    Ozawa, Sachiko
    Portnoy, Allison
    Getaneh, Hiwote
    Clark, Samantha
    Knoll, Maria
    Bishai, David
    Yang, H. Keri
    Patwardhan, Pallavi D.
    HEALTH AFFAIRS, 2016, 35 (11) : 2124 - 2132
  • [26] Preparing for the unthinkable: The resurgence of vaccine-preventable diseases
    Shah, Samir S.
    Shaughnessy, Erin E.
    Kinnear, Benjamin
    JOURNAL OF HOSPITAL MEDICINE, 2025,
  • [27] The increasing threat of vaccine-preventable diseases in Lebanon
    Porter, George James
    Kanaan, Wafaa
    Hamadeh, Randa
    Owens, Stephen
    Vadi, Ram
    Maddah, Diana
    EASTERN MEDITERRANEAN HEALTH JOURNAL, 2024, 30 (12) : 810 - 811
  • [28] Recognizing Vaccine-Preventable Diseases and Managing Outbreaks
    Hamilton, Jennifer L.
    PRIMARY CARE, 2020, 47 (03): : 467 - 481
  • [29] The situation of vaccine-preventable infectious diseases in Germany
    Oppermann, H
    GESUNDHEITSWESEN, 2001, 63 (02) : 102 - 106
  • [30] In the mood for wiping out vaccine-preventable diseases
    de Quadros, Ciro
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2014, 92 (04) : 236 - 237